2001
DOI: 10.1016/s0958-1669(00)00197-x
|View full text |Cite
|
Sign up to set email alerts
|

Industrial choices for protein production by large-scale cell culture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
283
0
4

Year Published

2002
2002
2018
2018

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 493 publications
(290 citation statements)
references
References 30 publications
0
283
0
4
Order By: Relevance
“…Spin-filters (SF) have been proposed as cell retention devices for animal cell culture several decades ago (Himmelfarb et al 1969) and became a popular device for perfusion cultivations both for small-scale studies and large-scale processes (Castilho and Medronho 2002;Chu and Robinson 2001;Figueredo et al 2005). They can be either placed inside the bioreactor (internal spin-filters) or in an external recirculation loop.…”
Section: Introductionmentioning
confidence: 99%
“…Spin-filters (SF) have been proposed as cell retention devices for animal cell culture several decades ago (Himmelfarb et al 1969) and became a popular device for perfusion cultivations both for small-scale studies and large-scale processes (Castilho and Medronho 2002;Chu and Robinson 2001;Figueredo et al 2005). They can be either placed inside the bioreactor (internal spin-filters) or in an external recirculation loop.…”
Section: Introductionmentioning
confidence: 99%
“…Microcarriers are used routinely in animal cell culture for the growth of anchorage-dependent cells and are among the established technological platforms for industrial production (8). Yet, there are only sporadic reports on their use in insect cell culture mainly because of the anchorage-independent nature of most cell lines and the one-shot, lytic nature of the BEVS.…”
Section: Introductionmentioning
confidence: 99%
“…Mammalian cells continue to be the organism of choice for producing complex biopharmaceuticals because of their ability to perform the desired post translational modifications that are essential for in vivo efficacy (Chu and Robinson 2001). Among the various classes of biopharmaceuticals, monoclonal antibodies are the dominant segment covering a broad range of medical indications and this trends expected to continue in the future (Kozlowski and Swann 2006;Reichert 2009).…”
Section: Introductionmentioning
confidence: 99%